Početna › Meduloblastom › Texas
Kliničke studije za Meduloblastom u državi Texas
8 studija za Meduloblastom traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 2
59 Months · Oba spola · Ažurirano 15. ruj 2026. · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
U tijeku regrutacijaFaza 2
Do 19 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
36 Months – 22 Years · Oba spola · Ažurirano 4. ruj 2026. · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 3 do 50 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
U tijeku regrutacijaFaza 2
12 Months – 30 Years · Oba spola · Ažurirano 26. kol 2026. · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- i još 4
U tijeku regrutacijaFaza 3
Od 4 do 21 godina · Oba spola · Ažurirano 25. kol 2026. · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 2
Od 3 do 39 godina · Oba spola · Ažurirano 24. kol 2026. · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
U tijeku regrutacijaFaza 2
Do 21 godina · Oba spola · Ažurirano 12. kol 2026. · NCT04696029Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.